Scholar Rock Holding (SRRK) Stock Highlights

8.27 | +0.36%

2024-09-19 03:59:49

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The companys lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle.

Statistics

Range Today

7.99 8.49

Volume Today 601.4K

Range 1 Year

5.94 21.17

Volume 1 Year 212.66M

Range 3 Year

4.32 41.27

Volume 3 Year 421.67M

Range 10 Year

4.32 70

Volume 10 Year 668.66M

Highlights

Market Capitalization 685.88M (small)

Floating Shares 55.46M

Current Price 8.27

Price To Earnings -3.63

Price To Book 5.13

Earnings Per Share -2.3

Payout Ratio 0%

Performance

Latest +0.36%

1 Month -11.83%

3 Months -5.49%

6 Months -41.88%

1 Year +30.44%

3 Years -79.16%

5 Years -30.09%

10 Years -45.63%

Benchmarks

Market Capitalization

113 / 368

Gross Profits

234 / 278

Total Revenue

295 / 300

Total Rank

258 / 368

Free Cashflow

254 / 352

Performance 5 years

174 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.